Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | 17-AAG | 0.0033113 | uM | 10 | 625.00 | 172.23 | 585.00 | 433.50 | 1.3495 | 1.5048 |
| MCF7 | Linsitinib | 1 | uM | 10 | 625.00 | 172.23 | 354.00 | 433.50 | 0.8166 | 0.7178 |
| MCF7 | Lapatinib | 0.0016596 | uM | 10 | 625.00 | 172.23 | 486.00 | 433.50 | 1.1211 | 1.1793 |
| MCF7 | 0 | uM | 10 | 625.00 | 172.23 | 590.00 | 433.50 | 1.3610 | 1.5209 | |
| MCF7 | Linsitinib | 0.0033113 | uM | 10 | 625.00 | 172.23 | 624.00 | 433.50 | 1.4394 | 1.6292 |
| MCF7 | Linsitinib | 0.1 | uM | 10 | 625.00 | 172.23 | 374.00 | 433.50 | 0.8628 | 0.7901 |
| MCF7 | Lapatinib | 0.31623 | uM | 10 | 625.00 | 172.23 | 608.00 | 433.50 | 1.4025 | 1.5784 |
| MCF7 | Linsitinib | 0.031623 | uM | 10 | 625.00 | 172.23 | 574.00 | 433.50 | 1.3241 | 1.4694 |
| MCF7 | 17-AAG | 10 | uM | 10 | 625.00 | 172.23 | 159.00 | 433.50 | 0.3668 | -0.0582 |
| MCF7 | Lapatinib | 0.1 | uM | 10 | 625.00 | 172.23 | 475.00 | 433.50 | 1.0957 | 1.1421 |
| MCF7 | 17-AAG | 0.31623 | uM | 10 | 625.00 | 172.23 | 168.00 | 433.50 | 0.3875 | -0.0185 |
| MCF7 | Linsitinib | 10 | uM | 10 | 625.00 | 172.23 | 227.00 | 433.50 | 0.5236 | 0.2304 |
| MCF7 | Linsitinib | 0.31623 | uM | 10 | 625.00 | 172.23 | 351.00 | 433.50 | 0.8097 | 0.7068 |
| MCF7 | Erlotinib | 0.31623 | uM | 10 | 625.00 | 172.23 | 554.00 | 433.50 | 1.2780 | 1.4045 |
| MCF7 | Erlotinib | 3.1623 | uM | 10 | 625.00 | 172.23 | 471.00 | 433.50 | 1.0865 | 1.1286 |
| MCF7 | Erlotinib | 1 | uM | 10 | 625.00 | 172.23 | 507.00 | 433.50 | 1.1696 | 1.2496 |
| MCF7 | 0 | uM | 10 | 625.00 | 172.23 | 387.00 | 433.50 | 0.8927 | 0.8367 | |
| MCF7 | 0 | uM | 10 | 625.00 | 172.23 | 333.00 | 433.50 | 0.7682 | 0.6407 | |
| MCF7 | Linsitinib | 3.1623 | uM | 10 | 625.00 | 172.23 | 240.00 | 433.50 | 0.5536 | 0.2830 |
| MCF7 | Linsitinib | 0.01 | uM | 10 | 625.00 | 172.23 | 407.00 | 433.50 | 0.9389 | 0.9075 |
| MCF7 | Erlotinib | 19.9526 | uM | 10 | 625.00 | 172.23 | 660.00 | 433.50 | 1.5225 | 1.7423 |
| MCF7 | 17-AAG | 0.0016596 | uM | 10 | 625.00 | 172.23 | 476.00 | 433.50 | 1.0980 | 1.1455 |
| MCF7 | 17-AAG | 1 | uM | 10 | 625.00 | 172.23 | 168.00 | 433.50 | 0.3875 | -0.0185 |
| MCF7 | Erlotinib | 0.1 | uM | 10 | 625.00 | 172.23 | 477.00 | 433.50 | 1.1003 | 1.1489 |
| MCF7 | 17-AAG | 0.031623 | uM | 10 | 625.00 | 172.23 | 227.00 | 433.50 | 0.5236 | 0.2304 |